Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Københavns Universitet is currently addressing 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 3 distinct examiners and 2 distinct art units. Alisha Jitendra Sircar is the busiest examiner, managing 1 pending office action. The distribution of 3 examiners for 3 actions indicates that each pending matter is being reviewed by a different official.
The presence of 3 pending actions across 2 distinct art units suggests that the university's research is concentrated in specific mechanical or medical fields. With 3 distinct examiners involved, the university must manage 3 separate prosecution tracks simultaneously. This decentralized approach means that no single examiner has a broad view of the university's current pending portfolio. The fact that Alisha Jitendra Sircar is the busiest examiner with only 1 pending action reflects a highly distributed workload across the patent office for these specific applications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SIRCAR, ALISHA JITENDRA | 1 | 58.1% | +58.1% |
| HAN, SETH | 1 | 59.6% | +28.8% |
| CRUM, MARY ABOU NADER | 1 | 40.4% | +65.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18553048 | MULTILAYERED PATCH | HAN, SETH | 72d overdue |
| 18907603 | CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE (CIED) WITH CARDIAC EVENT PREDICTION | SIRCAR, ALISHA JITENDRA | — |
| 18022026 | PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS | CRUM, MARY ABOU NADER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18553048 | MULTILAYERED PATCH | HAN, SETH | 72d overdue |
| 18907603 | CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE (CIED) WITH CARDIAC EVENT PREDICTION | SIRCAR, ALISHA JITENDRA | — |
| 18022026 | PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS | CRUM, MARY ABOU NADER | — |
| Art Unit | Apps |
|---|---|
| 3781 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18907603 | CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE (CIED) WITH CARDIAC EVENT PREDICTION | SIRCAR, ALISHA JITENDRA | — | §101§102DP | Non-Final OA | — | Pending | Oct 07, 2024 |
| 18553048 | MULTILAYERED PATCH | HAN, SETH | 3781 | §103§112 | Final Rejection | 72d overdue | Pending | Sep 28, 2023 |
| 18022026 | PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS | CRUM, MARY ABOU NADER | 1657 | §101§102§112 | Non-Final OA | — | Pending | Feb 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial